ENSC·293602504·US·equity·Healthcare - Biotechnology-13D/G
ENSC (ENSYSCE BIOSCIENCES INC) is held by 8 institutional investors as of Q1 2026. Largest holders: ADAGE CAPITAL PARTNERS GP, L.L.C. ($80,619), GEODE CAPITAL MANAGEMENT, LLC ($39,784), CITADEL ADVISORS LLC ($30,890). Net institutional sentiment: Mixed.
See how ENSC's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer